From: RhoA: A therapeutic target for chronic myeloid leukemia
fMLP Stimulation | PMNL | Sample Distribution | |
---|---|---|---|
 |  | Non-normal | Normal |
Unstimulated | Normal | 14% | 86% |
 | CML | 32% | 68% |
0.5 min | Normal | 14% | 86% |
 | CML | 45% | 55% |
5 min | Normal | 14% | 86% |
 | CML | 32% | 68% |
10 min | Normal | 21% | 79% |
 | CML | 36% | 64% |
30 min | Normal | 14% | 86% |
 | CML | 55% | 45% |
45 min | Normal | 21% | 79% |
 | CML | 18% | 82% |